SCHEMBL11226310

SCHEMBL11226310

CC1N(C)C(=O)COC12CCN(CC(O)C1COc3ccccc3O1)CC2

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 8/20 0.39
LTA4H P09960 4/20 0.37
LMNA P02545 2/20 0.37
MAPT P10636 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
ALDH1A1 P00352 3/20 0.36
MEN1 O00255 2/20 0.35
CYP2D6 P10635 2/20 0.35
CYP2C19 P33261 2/20 0.35
KMT2A Q03164 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
TSHR P16473 1/20 0.35
NFKB1 P19838 1/20 0.35
HIF1A Q16665 1/20 0.35
NR1I2 O75469 1/20 0.35
HTR1A P08908 1/20 0.35
ADRA2A P08913 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11227230 0.89 ALDH1A1 (0.38) DRD2LTA4HLMNAMAPTSMN1; SMN2
SCHEMBL11218476 0.89 LMNA (0.38) DRD2LTA4HLMNAMAPTSMN1; SMN2
SCHEMBL11219477 0.89 DRD2 (0.38) DRD2LTA4HLMNAMAPTSMN1; SMN2
SCHEMBL11225550 0.83 DRD2 (0.39) DRD2LTA4HLMNAMAPTSMN1; SMN2
SCHEMBL11228036 0.82 SIGMAR1 (0.52) DRD2LTA4HLMNAMAPTSMN1; SMN2
SCHEMBL11222769 0.82 DRD2 (0.35) DRD2LTA4HLMNAMAPTSMN1; SMN2
SCHEMBL11236321 0.81 DRD2 (0.46) DRD2LMNAALDH1A1MEN1CYP2D6
SCHEMBL11234763 0.80 ALDH1A1 (0.38) DRD2LTA4HLMNAMAPTSMN1; SMN2
SCHEMBL11226092 0.80 LMNA (0.38) DRD2LTA4HLMNAMAPTSMN1; SMN2
SCHEMBL11230875 0.79 SIGMAR1 (0.40) DRD2LTA4HLMNAMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4353901-A HYPERTENSION, CONGESTIVE HEART FAILURE, ARRHYTHMIAMIGRAINE, VASOSPASTIC DISORDERS, ASTHMA SYNTEX (U.S.A.) INC. (US) 1982-10-12 US disclosed